Stocks · Health care · Pharmaceutical Preparations

Nkarta, Inc.

NKTX Clue Score29
United States Fiscal year ends December CIK 0001787400 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Simeon George
27 Mar 2024
Director
Buy indirect
451,659
$10.00
$4.52M
Simeon George
27 Mar 2024
Director
Buy indirect
1,548,341
$10.00
$15.48M
Ra Capital Management, L.p.
27 Mar 2024
Director
Buy indirect
3,000,000
$10.00
$30.00M
Simeon George
28 Apr 2022
Director
Buy indirect
666,666
$15.00
$10.00M
Simeon George
28 Apr 2022
Director
Buy indirect
666,667
$15.00
$10.00M
Ra Capital Management, L.p.
26 Apr 2022
Director
Buy indirect
2,200,000
$15.00
$33.00M
James E Flynn
14 Jul 2020
10% owner
Buy indirect
500,000
$18.00
$9.00M
James E Flynn
14 Jul 2020
10% owner
Buy indirect
500,000
$18.00
$9.00M
Ra Capital Management, L.p.
14 Jul 2020
10% owner
Buy indirect
3,333,333
$18.00
$60.00M
Novo Holdings A/S
14 Jul 2020
10% owner
Buy
555,555
$18.00
$10.00M
Anthony A. Florence Jr.
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Forest Baskett
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Joshua Makower
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Mohamad Makhzoumi
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Peter W. Sonsini
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Scott D Sandell
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
New Enterprise Associates 15, L.P.
14 Jul 2020
10% owner
Buy
666,666
$18.00
$12.00M
GSK plc
14 Jul 2020
Director
Buy indirect
833,333
$18.00
$15.00M

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 24
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 26,112,417
Sales filed before the plan box existed 17
History held since 13 Jul 2020